Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 14, 2005; 11(10): 1445-1451
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1445
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1445
Variables | Paxillin | P | |
- | + | ||
Serum AFP level | |||
≤25 ng/mL (n = 22) | 13 | 9 | 0.604 |
>25 ng/mL (n = 29) | 15 | 14 | |
HBsAg | |||
Positive (n = 16) | 8 | 8 | 0.638 |
Negative (n = 35) | 20 | 15 | |
Microsatellite nodule | |||
Absent (n = 31) | 17 | 14 | 0.991 |
Present (n = 20) | 11 | 9 | |
Tumor size | |||
≤3 cm (n = 18) | 8 | 10 | 0.272 |
>3 cm (n = 33) | 20 | 13 | |
Cirrhosis | |||
Absent (n = 36) | 20 | 16 | 0.886 |
Present (n = 15) | 8 | 7 | |
Necrosis | |||
Absent (n = 24) | 13 | 11 | 0.922 |
Present (n = 27) | 15 | 12 | |
Portal vein thrombosis | |||
Absent (n = 37) | 24 | 13 | 0.021 |
Present (n = 14) | 4 | 10 | |
Differentiation | |||
Well (n = 35) | 24 | 11 | 0.004 |
Low (n = 16) | 4 | 12 | |
Extra-hepatic metastasis | |||
Absent (n = 41) | 26 | 15 | 0.014 |
Present (n = 10) | 2 | 8 |
- Citation: Li HG, Xie DR, Shen XM, Li HH, Zeng H, Zeng YJ. Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J Gastroenterol 2005; 11(10): 1445-1451
- URL: https://www.wjgnet.com/1007-9327/full/v11/i10/1445.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i10.1445